News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,530 Results
Type
Article (14260)
Company Profile (9)
Press Release (131261)
Section
Business (39385)
Career Advice (206)
Deals (5313)
Drug Delivery (16)
Drug Development (18419)
Employer Resources (25)
FDA (2831)
Job Trends (3143)
News (65291)
Policy (5278)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
Academia (1698)
Accelerated approval (1)
Adcomms (11)
Allergies (13)
Alliances (12535)
ALS (19)
Alzheimer's disease (472)
Antibody-drug conjugate (ADC) (18)
Approvals (2842)
Artificial intelligence (66)
Autoimmune disease (1)
Automation (2)
Bankruptcy (31)
Best Places to Work (2686)
BIOSECURE Act (14)
Biosimilars (7)
Biotechnology (6)
Bladder cancer (19)
Brain cancer (9)
Breast cancer (72)
Cancer (584)
Cardiovascular disease (31)
Career advice (193)
Career pathing (4)
CAR-T (39)
Cell therapy (100)
Cervical cancer (10)
Clinical research (14190)
Collaboration (195)
Compensation (10)
Complete response letters (2)
COVID-19 (1021)
CRISPR (11)
C-suite (54)
Cystic fibrosis (22)
Data (457)
Denatured (4)
Depression (3)
Diabetes (32)
Diagnostics (1622)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (25)
Drug pricing (19)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (8939)
Editorial (6)
Employer branding (3)
Employer resources (20)
Events (18589)
Executive appointments (133)
FDA (3055)
Featured Employer (2)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (258)
Gene editing (20)
Generative AI (2)
Gene therapy (87)
GLP-1 (103)
Government (1132)
Guidances (10)
Healthcare (4818)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (11)
Indications (3)
Infectious disease (1052)
Inflammatory bowel disease (31)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (11)
Interviews (19)
IPO (2710)
IRA (12)
Job creations (546)
Job search strategy (183)
Kidney cancer (5)
Labor market (7)
Layoffs (45)
Leadership (1)
Legal (920)
Liver cancer (20)
Lung cancer (95)
Lymphoma (37)
Machine learning (2)
Management (6)
Manufacturing (49)
MASH (10)
Medical device (2400)
Medtech (2400)
Mergers & acquisitions (2727)
Metabolic disorders (60)
Multiple sclerosis (15)
NASH (4)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (574)
NextGen: Class of 2025 (1601)
Non-profit (1867)
Northern California (422)
Now hiring (5)
Obesity (20)
Opinion (46)
Ovarian cancer (26)
Pain (19)
Pancreatic cancer (15)
Parkinson's disease (30)
Partnered (5)
Patents (25)
Patient recruitment (24)
Peanut (9)
People (15064)
Pharmaceutical (5)
Phase I (4801)
Phase II (6524)
Phase III (4304)
Pipeline (201)
Podcasts (4)
Policy (42)
Postmarket research (547)
Preclinical (2203)
Press Release (18)
Prostate cancer (23)
Psychedelics (10)
Radiopharmaceuticals (47)
Rare diseases (72)
Real estate (1194)
Recruiting (11)
Regulatory (3610)
Reports (9)
Research institute (1864)
Resumes & cover letters (16)
RNA editing (1)
RSV (5)
Schizophrenia (11)
Series A (41)
Series B (16)
Sickle cell disease (19)
Southern California (386)
Spinal muscular atrophy (23)
Sponsored (1)
Startups (1064)
Stomach cancer (3)
Supply chain (12)
Tariffs (1)
United States (4227)
Vaccines (201)
Venture capitalists (11)
Webinars (3)
Weight loss (9)
Women's health (3)
Worklife (3)
Date
Today (13)
Last 7 days (154)
Last 30 days (545)
Last 365 days (6811)
2025 (1628)
2024 (7196)
2023 (8690)
2022 (11528)
2021 (12836)
2020 (12162)
2019 (10908)
2018 (8075)
2017 (7334)
2016 (7413)
2015 (8719)
2014 (6455)
2013 (5322)
2012 (5396)
2011 (5626)
2010 (4800)
Location
Africa (190)
Alabama (29)
Alaska (3)
Arizona (46)
Arkansas (3)
Asia (9149)
Australia (2040)
California (983)
Canada (329)
China (64)
Colorado (46)
Connecticut (44)
Delaware (33)
Europe (19024)
Florida (204)
Georgia (21)
Idaho (11)
Illinois (111)
India (5)
Indiana (44)
Japan (36)
Kansas (20)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (150)
Massachusetts (725)
Michigan (27)
Minnesota (63)
Missouri (24)
Montana (6)
Nebraska (4)
Nevada (4)
New Hampshire (12)
New Jersey (451)
New Mexico (6)
New York (351)
North Carolina (153)
North Dakota (3)
Northern California (422)
Ohio (45)
Oklahoma (5)
Oregon (8)
Pennsylvania (228)
Rhode Island (6)
South America (247)
South Carolina (5)
Southern California (386)
Tennessee (20)
Texas (218)
Utah (29)
Virginia (26)
Washington D.C. (31)
Washington State (122)
West Virginia (1)
Wisconsin (8)
145,530 Results for "whitehead institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Patient’s Perspective with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis talks to Tom Whitehead, co-founder of the Emily Whitehead Foundation, about how standard care, cell and gene therapies and their impact on patients.
January 30, 2025
·
1 min read
·
Lori Ellis
Business
Navigating Patient Journeys with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis and Tom Whitehead continue to discuss the patient and caregiver experience, where Tom gives his insights to the future of CGTs.
February 13, 2025
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Business
Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology
Chroma Medicine, Inc. (Chroma) a genomic medicine company pioneering single-course epigenetic editing therapeutics, today announced it has entered into an exclusive license agreement with the Whitehead Institute to access intellectual property and technology developed in the lab of Chroma co-founder Jonathan Weissman, Ph.D.
June 27, 2024
·
2 min read
Press Releases
Emily Whitehead Foundation Names George Eastwood Executive Director, Darshan Kulkarni Board Chair
January 30, 2025
·
3 min read
Biotech Beach
Shoreline Biosciences Wins a Comprehensive Summary Judgement Victory on All Claims Brought by Fate Therapeutics and Whitehead Institute on IPSC Generation and Use
Shoreline Biosciences, Inc. announced a major milestone in its patent litigation with Fate Therapeutics, Inc. and the Whitehead Institute in the U.S. District Court for the Southern District of California.
September 7, 2023
·
2 min read
Policy
Ousted Whitehead Institute Researcher David Sabatini Up for Position at NYU
David Sabatini, who was ousted last year by the Whitehead Institute over allegations of sexual harassment, may have found a new home at the NYU Grossman School of Medicine.
April 27, 2022
·
3 min read
·
Alex Keown
Press Releases
Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery
March 3, 2025
·
5 min read
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
1 of 14,553
Next